Vion Pharmaceuticals

Vion Pharmaceuticals Receives Response From FDA on Special Protocol Assessment for Onrigin(TM)
Vion Pharmaceuticals Receives Response From FDA on Special Protocol Assessment for Onrigin(TM)
Yahoo/PR NewsWire
Vion Pharmaceuticals
Flag link:
Biotech Calendar: Key Dates for December
Biotech Calendar: Key Dates for December
TheStreet.com
Exelixis
Dyax
OSI Pharmaceuticals
Isis Pharmaceuticals
Somaxon
Gilead Sciences
Eli Lilly
Vion Pharmaceuticals
Roche
Immunogen
Auxilium
BioDelivery Sciences
Arena Pharmaceuticals
Vivus
Synta
Flag link:
Vion Makes Case for Leukemia Drug to FDA Panel
Vion Makes Case for Leukemia Drug to FDA Panel
TheStreet.com
Vion Pharmaceuticals
FDA
leukemia
Onrigin
Flag link:
Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval
Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval
Seeking Alpha
Vion Pharmaceuticals
FDA
Onrigin
AML
Flag link:
Vion Pharmaceuticals: Onrigin application accepted but barriers remain
Vion Pharmaceuticals: Onrigin application accepted but barriers remain
Pharmaceutical Business Review
Vion Pharmaceuticals
Onrigin
FDA
leukemia
Flag link:
Updated FDA, Clinical Trial Calendars: Vion, Discovery Labs, Northfield Labs
Updated FDA, Clinical Trial Calendars: Vion, Discovery Labs, Northfield Labs
Seeking Alpha
drug trials
Northfield Laboratories
Discovery Labs
Vion Pharmaceuticals
Flag link:
Vion files new drug application for leukemia drug
Vion files new drug application for leukemia drug
Pharmaceutical Business Review
Vion Pharmaceuticals
FDA
leukemia
Onrigin
AML
NDA
Flag link: